Related Experiment Video
Updated: Oct 4, 2025

07:12
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
3.7K
Large-scale structural network change correlates with clinical response to rTMS in depression
Sean M Nestor1,2, Arsalan Mir-Moghtadaei3,4, Fidel Vila-Rodriguez5
1Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Summary
Structural network changes correlate with treatment response in major depressive disorder (MDD) patients undergoing repetitive transcranial magnetic stimulation (rTMS). These findings highlight the role of brain network plasticity in rTMS efficacy for depression.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Imaging
Background:
- Repetitive transcranial magnetic stimulation (rTMS) efficacy in major depressive disorder (MDD) varies, with underlying neural mechanisms involving large-scale brain networks.
- The relationship between structural network integrity, plasticity, and rTMS response in MDD remains unclear.
Purpose of the Study:
- To investigate the association between structural brain networks and clinical response to rTMS in MDD patients.
- To explore the neural mechanisms of rTMS therapy by analyzing structural covariance networks (SCNs).
Main Methods:
- Structural MRI data from 268 MDD patients and 70 healthy controls from the THREE-D trial were analyzed.
- Multivariate analyses characterized SCNs from cortical gray matter thickness, volume, and surface area.
- Association between pre-treatment SCNs and clinical improvement was assessed, along with post-treatment changes.
Main Results:
- Cortical thickness and volume SCNs differentiated MDD patients from controls (p=0.005).
- No significant association was found between pre-treatment SCNs and clinical improvement.
- An anticorrelated SCN between the left dorsolateral prefrontal cortex (DLPFC) and subgenual anterior cingulate cortex was identified (p=0.0004).
- Post-treatment changes in cortical thickness SCN architecture correlated with clinical improvement in responders (p=0.001).
Conclusions:
- Structural network changes, particularly post-treatment alterations in SCN architecture, may underlie clinical response to rTMS in MDD.
- SCNs are valuable tools for understanding depression pathophysiology and the neural mechanisms of plasticity in response to circuit-based treatments like rTMS.

